Product Description
The South Korea Dental Bone Graft Substitute and other biomaterials market was valued at almost $116 million in 2024. This is expected to increase over the forecast period at a CAGR of 5.2% to reach over $165 million.
The full report suite on the South Korean market for dental bone graft substitutes (DBGSs) and other biomaterials includes DBGSs, dental barrier membranes, local antimicrobial periodontal treatments and dental soft tissue wound care. Collectively, these segments will be referred to as the dental biomaterials market.
MARKET REPORT DATA TYPES INCLUDED
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Procedure Numbers
- Market Drivers & Limiters
- Market Forecasts Until 2031, and Historical Data to 2021
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
SOUTH KOREA DENTAL BONE GRAFT SUBSTITUTES MARKET TRENDS
- Geistlich was the leading competitor in the overall dental biomaterials market in South Korea in 2024. Its strong market position reflects its dominance in the xenograft segment. The Bio-Oss® bovine xenograft product line, widely regarded as the gold standard for xenografts, was the clear leader in the segment. In 2020, the company expanded the Bio-Oss® Collagen product line to include a new 50 mg size, designed for narrow defect procedures and minor vertical augmentations. Many dentists are familiar with Geistlich products due to early exposure during their dental education. However, the economic recession has influenced clinician purchasing behavior, leading some to shift toward companies offering broader product lines or more affordable regenerative materials. Geistlich’s leading position has been sustained by its flagship Bio-Gide® collagen membrane product line, which continues to dominate the dental barrier membrane market. Geistlich is expected to remain the undisputed leader in the DBGS market over the forecast period.
- Genoss was the second-leading competitor in the South Korean DBGS and dental biomaterials market in 2024. Genoss is a subsidiary of Dentium, one of the largest implant companies in South Korea, which has enabled it to benefit from bundling promotions with dental implant sales. Its DBGS products, particularly the OSTEON™ line of synthetic bone graft materials, have received a favorable response in the South Korean market. As a result, sales of its resorbable collagen membrane products have also increased. Genoss currently distributes several membrane products in South Korea. In 2007, the company launched its first barrier membrane product in the South Korean market: OSTEOGUIDE™, a non-resorbable membrane composed of bovine collagen and hydroxyapatite (HA).
- Hans Biomed was the first Asian company to commercialize human skin and bone grafting materials. The company offers a range of medical products, including silicones and hair transplants; however, bone grafting products account for a significant portion of its overall revenue. In South Korea, Hans Biomed was the first company to receive a KFDA license and to establish a tissue bank. In 2024, Hans Biomed held a notable share of the DBGS and other dental biomaterials market through the sale of its allograft products.
SOUTH KOREA DENTAL BONE GRAFT SUBSTITUTES MARKET SEGMENTATION SUMMARY
- Dental Bone Graft Substitute (DBGS) Market – Further Segmented Into:
- Type: Mineralized Allografts, Demineralized Bone Matrix (DBM) Allografts, Xenografts, Synthetics.
- Dental Barrier Membrane Market – Further Segmented Into:
- Type: Resorbable, and Non-Resorbable.
- Material: Xenografts, Synthetics, and Allografts.
- Antimicrobial Periodontal Treatment Market
- Dental Soft Tissue Wound Care Market – Further Segmented Into:
- Type: Plugs, Tape, and Foam.
*Segment is analyzed at a unit level only.
GLOBAL RESEARCH SCOPE
Report Attribute | Details |
---|---|
Region | Asia Pacific (South Korea) |
Base Year | 2024 |
Forecast | 2025-2031 |
Historical Data | 2021-2023 |
Quantitative Coverage | Procedure Numbers, Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
Qualitative Coverage | Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
CONTACT US FOR ADDITIONAL INFORMATION
For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.